Chemistry: molecular biology and microbiology – Process of mutation – cell fusion – or genetic modification – Introduction of a polynucleotide molecule into or...
Reexamination Certificate
2008-05-27
2008-05-27
Wehbé, Anne Marie (Department: 1633)
Chemistry: molecular biology and microbiology
Process of mutation, cell fusion, or genetic modification
Introduction of a polynucleotide molecule into or...
C435S320100, C435S325000, C435S372000, C435S377000, C424S093210, C424S093710
Reexamination Certificate
active
07378277
ABSTRACT:
Recombinant dendritic cells are made by transforming a stem cell and differentiating the stem cell into a dendritic cell. The resulting dendritic cell is an antigen presenting cell which activates T cells against MHC class I-antigen targets. Kits, assays and therapeutics are based upon the activation of T cells by the recombinant dendritic cell. Cancer, viral infections and parasitic infections are all ameliorated by the recombinant dendritic cells, or corresponding activated T cells. Therapeutic compositions and pharmaceutical compositions are provided.
REFERENCES:
patent: 0563485 (1993-10-01), None
patent: WO 93/18137 (1993-09-01), None
patent: WO 94/16716 (1994-08-01), None
patent: WO 94/27435 (1994-12-01), None
patent: WO 95/06120 (1995-03-01), None
patent: WO 95/34676 (1995-12-01), None
patent: WO 97/03703 (1997-02-01), None
Alijagic et al. (1995) Eur. J. Immunol., vol. 25, 3100-3107.
Chen et al. (1995) Proc. Natl. Acad. Sci., vol. 18(2), 8125-8129.
Deonarain et al. (1998) Exp. Opin. Ther. Patents, vol. 8 (1).
Miller et al. (1995) FASEB, vol. 9.
Conry et al., “Selected strategies to augment polynucleotide immunization”,Gene Therapy3:1: 67-74 (1996).
Heemskerk et al., “Melanoma-specific CTL, generated in vitro using dendritic antigens”, (Meeting abstract),Gene Therapy of Cancer: 2nd European Conference, Sep. 7-8, 1995, London, A13, XP000675471.
Reeves et al., “Retroviral transduction of human dendritic cells with a tumor-associated antigen gene”,Cancer Res56:24:5672-5677 (1996).
Rouse et al., “Induction in vitro of primary cytotoxic T-lymphocyte responses with DAN encoding herpes simplex virus proteins”,J. Virol., 68:9:5685-5689 (1994).
Drexhage et al., “Dendritic Cells: Antigen Presenting Cells of T and B Lymphocytes”, Ci-204-Ci-207, 1994.
Alijagic et al., “Dendritic cells generated from peripheral blood transfected with human tyrpsomase induce specific T cell activation”,Eur. J. Immunol.25:3100-3107 (1995).
Holland et al., “Differentiation of Human Hematopoietic Cells Increases Expression of a Gone Transferred by a Retroviral Vector”,Journal of Leukocyte Biology46:221-229 (1989).
Siena et al., “Massive ex vivo generated of functional dendritic cells from CD34 blood progenitors for anticancer therapy”,Experimental Hematology23:1463-1471 (1995).
Bakker et al., “Generation of antimelanoina cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic cells in vitro”,Cancer Res.55:22: 5330-5334 (1995).
Boehmelt et al., “Dendritic cell progenitor is transformed by a conditional v-Rel estrogen receptor fusion protein v-Re1ER”,Cell80:2: 341-352 (1995).
Chen et al., “Cytokine-mobilized peripheral blood CD34+THy-1+Lin-human hematopoietic stem cells as target cells for transplantation-based gene therapy”,Leukemia9 Suppl 1:S17-S25 (1995).
Hwu Patrick
Reeves Mark
Rosenberg Steven A.
The United States of America as represented by the Department of
Townsend and Townsend / and Crew LLP
Wehbe Anne Marie
LandOfFree
Methods and compositions for transforming dendritic cells... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for transforming dendritic cells..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for transforming dendritic cells... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2804020